The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy

Area of Science:

• Biochemistry and Molecular Biology
• Cancer Research
• Cell Death Mechanisms

Background:

• Ferroptosis is an iron-dependent form of regulated cell death.
• It is characterized by lipid peroxidation and accumulation of intracellular lipid reactive oxygen species (L-ROS).
• Erastin is a small molecule compound initially identified for its tumor-selective killing properties.

Purpose of the Study:

• To review the role of erastin as an inducer of ferroptosis.
• To elucidate the molecular mechanisms by which erastin mediates ferroptosis.
• To highlight the potential of erastin in cancer therapy.

Main Methods:

• Review of existing scientific literature on erastin and ferroptosis.
• Analysis of molecular pathways involving erastin, system Xc-, VDAC, and p53.
• Examination of erastin's impact on cancer cell sensitivity to conventional therapies.

Main Results:

• Erastin induces ferroptosis through interactions with system Xc-, VDAC, and p53.
• Erastin enhances the sensitivity of tumor cells to chemotherapy and radiotherapy.
• Erastin demonstrates selective killing of tumor cells expressing specific markers (e.g., RAS^V12).

Conclusions:

• Erastin is a potent inducer of ferroptosis with significant therapeutic potential in oncology.
• Understanding erastin's mechanisms provides a foundation for developing novel cancer treatments.
• Erastin-based therapies offer a promising avenue for overcoming treatment resistance.